Hepatic lesion detection: Comparison of MR imaging superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis

Radiology

Volumn 210, Issue 2, 1999, Pages 459-466

  Ward, Janice ^a   Naik, Katherine S ^a   Guthrie, J Ashley ^a   Wilson, Daniel ^a   Robinson, Philip J ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Colon, neoplasms; Iron; Live neoplasms, MR; Liver neoplasms, CT; Liver neoplasms, metastases; Magnetic resonance (MR), comparative studies; Receiver operating characteristic curve (ROC)

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

EID: 0032956637     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.210.2.r99fe05459     Document Type: Article

References (35)

1. Hollett MD, Jeffrey RB, Nino-Murcia M, Jorgensen MJ, Harris DP. Dual-phase CT of the liver: value of arterial phase scans in the detection of small (≤1.5 cm) malignant hepatic neoplasms. AJR 1995; 164: 879-884.
2. Choi BI, Cho JM, Han JK, Choi DS, Han MC. Spiral CT for the detection of hepatocellular carcinomas: relative value of arterial- and late-phase scanning. Abdom Imaging 1996; 21:440-444.
3. Oliver JH, Baron RL, Federle MP, Rockette HE. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR 1996; 167:71-77.
4. Bonaldi VM, Bret PM, Reinhold C, Atri M. Helical CT of the liver: value of an early hepatic arterial phase. Radiology 1995; 197:357-363.
5. Soyer P. CT during arterial portography. Eur Radiol 1996; 6:349-357.
6. Matsui O, Takashima T, Kadoya M, et al. Dynamic computed tomography during arterial portography: the most sensitive examination for small hepato-cellular carcinomas. J Comput Assist Tomogr 1985; 9:19-24.
7. Heiken JP, Weyman PJ, Lee JK, et al. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. Radiology 1989; 171:47-51.
8. Hagspiel KD, Neidl KFW, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced MR imaging at 1.5T with dynamic CT, intraoperative US and percutaneous US. Radiology 1995; 196:471-178.
9. Metz CE. ROC methodology in radiological imaging. Invest Radiol 1986; 21:720-733.
10. Chakraborty DP, Winter LHL. Free response methodology: alternate analysis and a new observer-performance experiment. Radiology 1990; 174:873-881.
11. Sheiner PA, Brower ST. Treatment of metastatic cancer to the liver. Semin Liver Dis 1994; 14:169-177.
12. Sugarbaker PH. Surgical decision making for large bowel cancer metastatic to the liver. Radiology 1990; 174:621-626.
13. Saini S, Stark D, Hahn PF, et al. Ferrite particles: a superparamagnetic contrast agent for the reticuloendothelial system. Radiology 1987; 162:211-216.
14. Stark DD, Weissleder R, Elizondo G, et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988; 168:297-301.
15. Weissleder R, Stark DD, Englestad BL, et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR 1989; 152: 167-173.
16. Fretz CJ, Stark DD, Metz CE, et al. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MRI and iron-oxide enhanced MR imaging. AJR 1990; 155:763-770.
17. Ferrucci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR 1990; 155:943-950.
18. Bellin MR, Zaim S, Auberton E, et al. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide MR imaging. Radiology 1994; 193:657-663.
19. Ros PR, Freeny PC, Harms SE, et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995; 196:478-481.
20. Hamm B, Staks T, Taupitz M, et al. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. JMRI 1994; 4:659-668.
21. Reimer P, Rummeny EJ, Daldrup HE, et al. Clinical results with Resovist: a phase II clinical trial. Radiology 1995; 195:489-496.
22. Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996; 200: 785-792.
23. Nelson RC, Chezmar JL, Sugarbaker PH, Bernardino ME. Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. Radiology 1989; 172:27-34.
24. Soyer P, Levesque M, Elias D, Zeitoun G, Rocke A. Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography. Radiology 1992; 183:541-544.
25. Soyer P, Lacheheb D, Levesque M. False positive diagnosis based on CT portography: correlation with pathological findings. AJR 1992; 160:285-289.
26. Blakeborough A, Ward J, Wilson D, et al. Hepatic lesion detection at MR imaging: a comparative study with four sequences. Radiology 1997; 203:759-765.
27. Lu DSK, Saini S, Hahn PF, et al. T2-weighted MR imaging of the upper part of the abdomen: should fat suppression be used routinely? AJR 1994; 162:1095-1100.
28. Mueller D, Kopka L, Fischer U, Grabbe EH. Imaging of focal liver lesions with fast SPIO-MR imaging in comparison with triple phase helical-CT (abstr). Radiology 1997;205(P):371.
29. Lencioni RA, Laiolo E, Pinto F, Donati F, Giulianotti P, Bartolozzi C. Detection of liver metastases: prospective comparison of unenhanced and superparamagnetic iron oxide-enhanced MR imaging, dual-phase spiral-CT, and spiral CT during arterial portography (abstr). Radiology 1997; 205(P):371.
30. Wernecke K, Rummeny E, Bongartz G, et al. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT and MR imaging. AJR 1991; 157:731-739.
31. Oudkerk M, van den Heuvel AG, Wielopolski PA, Schmitz PIM, Rinkes IHMB, Wiggers T. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 1997; 203:449-456.
32. Ward J, Blakeborough A, Guthrie JA, Wilson D, Robinson PJ. Hepatic lesion detection following SPIO enhancement: a comparison of sequences at 1.0 Tesla (abstr). In: Proceedings of the Fifth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1997; 1:69.
33. Marchal G, Ven Hecke P, Demaerel P, et al. Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5T. AJR 1989; 152:771-775.
34. Halavaara JT, Lamminen AE, Bondestam S, Standertskjold-Nordenstam CG, Hamberg LM. Detection of focal liver lesions with superparamagnetic iron oxide: value of STIR and SE imaging. J Comput Assist Tomogr 1994; 18:897-904.
35. Van Beers BE, Lacrosse M, Jamart J, et al. Detection and segmental location of malignant hepatic tumours: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging. AJR 1997; 168:713-717.